# Merck Serono SA – FDA Inspection, Jun 16, 2011

Source: https://www.keypedia.com/records/fda_inspections/merck-serono-sa/ec28250f-7ba3-4d9b-a5ef-00d359890f9f
Source feed: FDA_Inspections

> FDA inspection 732616 of Merck Serono SA, June 16, 2011. Classification: Official Action Indicated (OAI). 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 732616
- Company Name: Merck Serono SA
- Inspection Date: 2011-06-16
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1298388 - 2025-11-25
- FDA Inspection 1209187 - 2023-05-02
- FDA Inspection 1122463 - 2020-02-18
- [FDA Inspection 1051545 - 2018-05-09](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/9b6ada5e-805a-412e-b05b-6de574a13d76)
- [FDA Inspection 947757 - 2015-11-06](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/3f6397d7-2aad-4229-b733-773978761e61)

Company: https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c